Nashik has reported its first case of Guillain-Barre Syndrome in a 60-year-old man. The condition, which causes the immune system to attack peripheral nerves, has been reported in 250 cases in ...

Chief Minister Devendra Fadnavis on Wednesday reviewed plans for the 2027 Kumbh Mela to be held in Nashik. The meeting was attended by Water Resources Minister Girish Mahajan, officials from 38 ...

32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...

Serum Institute of India, GlaxoSmithKline (GSK), Soligenix Inc., Curia, Cobra Biologics, BioReliance, Recipharm, Jubilant HollisterStier, and several others, are currently operating in the vaccine ...

Nashik: Starting Sept this year, 50 electric buses will be plying on the city roads. Centre has already approved 50 buses for the Nashik Municipal Corporation (NMC) and has also appointed a ...

Mr. Mukesh Ambani is the Managing Director and Chairman of Reliance Industries, and he holds the title of India’s richest person. According to the latest financial reports, Reliance Industries ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...

Our top 10 smartphones list includes the most powerful and feature-rich devices available in India, running on the latest versions of iOS and Android, with most Android flagships now featuring ...

HDFC Bank is the largest bank in India in terms of market cap and the thirteenth-largest bank in the world on the same terms. As one of the leading private banks in India, it holds a prominent ...

The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent to trade at Rs 2,684 apiece on February 18, extending gains for the second straight session after releasing ...

The company’s innovative Respiratory portfolio, led by Nucala and Trelegy, achieved robust growth, further expanding patient access across India, GlaxoSmithKline Pharmaceuticals said.